>>9037980
SEC. 706. Advances in life sciences and biotechnology.
(a) Requirement for plan.—Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence shall brief the congressional intelligence committees on a proposed plan to monitor advances in life sciences and biotechnology to be carried out by the Director.
(b) Contents of plan.—The plan required by subsection (a) shall include—(1) a description of the approach the elements of the intelligence community will take to make use of organic life science and biotechnology expertise within and outside the intelligence community on a routine and contingency basis;(2) an assessment of the current collection and analytical posture of the life sciences and biotechnology portfolio as it relates to United States competitiveness and the global bio-economy, the risks and threats evolving with advances in genetic editing technologies, and the implications of such advances on future biodefense requirements; and(3) an analysis of organizational requirements and responsibilities, including potentially creating new positions.
(c) Report to Congress.—Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence shall submit to the congressional intelligence committees, the Committee on Armed Services of the Senate, and the Committee on Armed Services of the House of Representatives a report and provide a briefing on the role of the intelligence community in the event of a biological attack on the United States, including an assessment of the capabilities and gaps in technical capabilities that exist to address the potential circumstance of a – NOVEL UNKNOWN PATHOGEN.
https://www.congress.gov/bill/114th-congress/house-bill/6393/text#toc-H1F34F7843955494592B6F04108572B27